Target intelligence / Profile preview

Streptococcus pneumoniae type 9V capsular polysaccharide antigen-specific B cell

01

Overview

The phrase "Streptococcus pneumoniae type 9V capsular polysaccharide antigen-specific B cells" does not refer to a single molecular target, but rather to a population of **B cells**—a type of immune cell—that recognize the capsular polysaccharide antigen of **Streptococcus pneumoniae serotype 9V**. These B cells produce antibodies specific for the type 9V capsular polysaccharide, which is a component of several pneumococcal vaccines and is used in studying immunogenicity and vaccine response. While the **capsular polysaccharide antigen** itself is a therapeutic target as a vaccine antigen, **antigen-specific B cells** are not themselves drug targets or recognized molecular entities, but rather functional lymphocyte subsets identified by their specificity for this antigen[3][6]. --- **Explanation and Justification:** - The query mixes the concept of a **molecule/antigen** (type 9V capsular polysaccharide) with a **cell population** (antigen-specific B cells). - **Streptococcus pneumoniae type 9V capsular polysaccharide antigen** is the actual vaccine antigen and can be considered a therapeutic target as a component of pneumococcal vaccines[3][6]. - **[Antigen]-specific B cells**, however, are not molecular targets but immune cells that recognize and respond to this antigen. - This means the query is **incorrect** for the purpose of molecular target curation—it does not describe a receptor, enzyme, transporter, or defined protein/nucleic acid, but rather an immune cell population defined by antigen specificity. - Therefore, most requested fields do not apply or should be null. For structured data, the correct approach is to reject this as a canonical molecular target and, if relevant, curate the *actual antigen* (the capsular polysaccharide) instead[3][6]. If you intend to curate the molecular target, the correct entry would be for the **Streptococcus pneumoniae type 9V capsular polysaccharide antigen** (see DrugBank[6], PubChem[3]), not the antigen-specific B cells.

Beyond the preview

Go deeper on Streptococcus pneumoniae type 9V capsular polysaccharide antigen-specific B cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae type 9V capsular polysaccharide antigen-specific B cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call